RADIENT PHARMACEUTICALS Corp Business Finance Contracts & Agreements
49 Contracts & Agreements
- Debenture Agreements (2 contracts)
- Escrow Agreements (2)
- Exchange Agreements (6)
- Investment Agreements (1)
- Loan Agreements (1)
- Note Agreements (10)
- Purchase Agreements (1)
- Registration Rights Agreements (4)
- Release Agreements (1)
- Stock Agreements (8)
- Waiver Agreements (3)
- Warrant Agreements (10)
- AMENDMENT TO INVESTMENT ADVISORYAGREEMENT (Filed With SEC on February 14, 2012)
- DEBENTURE AMENDMENT (Filed With SEC on February 14, 2012)
- CERTIFICATE OF DESIGNATIONS OF THE SERIES C CONVERTIBLE PREFERRED STOCK OF RADIENT PHARMACEUTICALS CORPORATION (Filed With SEC on November 29, 2011)
- [FORM OF SERIES B WARRANT] RADIENT PHARMACEUTICALS CORPORATION Warrant To Purchase Series C Convertible Preferred Stock (Filed With SEC on November 29, 2011)
- [FORM OF SERIES A WARRANT] RADIENT PHARMACEUTICALS CORPORATION Warrant To Purchase Common Stock (Filed With SEC on November 29, 2011)
- [FORM OF CONVERTIBLE NOTE] (Filed With SEC on November 29, 2011)
- CERTIFICATE OF DESIGNATIONS OF THE SERIES B CONVERTIBLE PREFERRED STOCK OF RADIENT PHARMACEUTICALS CORPORATION (Filed With SEC on November 29, 2011)
- EXCHANGE AGREEMENT (Filed With SEC on November 29, 2011)
- RELEASE AGREEMENT (Filed With SEC on August 29, 2011)
- CONVERTIBLE PROMISSORY NOTE (Filed With SEC on August 29, 2011)
- [FORM OF WARRANT] RADIENT PHARMACEUTICALS CORPORATION Warrant To Purchase Common Stock (Filed With SEC on July 1, 2011)
- [FORM OF CONVERTIBLE NOTE] (Filed With SEC on July 1, 2011)
- EXCHANGE AGREEMENT (Filed With SEC on July 1, 2011)
- Promissory Note (Filed With SEC on May 17, 2011)
- JADEPHARMACEUTICALS, INC. 10%CONVERTIBLE EXCHANGEABLE DEBENTURE DUE:December__, 20__ (Filed With SEC on February 4, 2011)
- REGISTRATIONRIGHTS AGREEMENT (Filed With SEC on January 31, 2011)
- FORMOF SERIES [A] [B] WARRANT (Filed With SEC on January 31, 2011)
- [FORMOF CONVERTIBLE NOTE] (Filed With SEC on January 31, 2011)
- EXCHANGEAGREEMENT (Filed With SEC on January 24, 2011)
- EXCHANGEAGREEMENT (Filed With SEC on January 24, 2011)
- RADIENTPHARMACEUTICALS CORPORATION WARRANTTO PURCHASE _______ SHARES OF COMMON STOCK (Filed With SEC on October 8, 2010)
- EXCHANGE AGREEMENT (Filed With SEC on August 12, 2010)
- RADIENT PHARMACEUTICALS CORPORATION FINAL ADDENDUM TO NOTE AND WARRANT PURCHASE AGREEMENT DATED:APRIL 8, 2010 (Filed With SEC on April 13, 2010)
- REGISTRATION RIGHTS AGREEMENT (Filed With SEC on April 13, 2010)
- RADIENT PHARMACEUTICALS CORPORATION WARRANT TO PURCHASE SHARES OF COMMON STOCK (Filed With SEC on April 13, 2010)
- RADIENT PHARMACEUTICALS CORPORATION Convertible Promissory Note (Filed With SEC on April 13, 2010)
- NOTE AND WARRANT PURCHASE AGREEMENT (Filed With SEC on April 13, 2010)
- REGISTRATION RIGHTS AGREEMENT (Filed With SEC on March 26, 2010)
- RADIENT PHARMACEUTICALS CORPORATION WARRANT TO PURCHASE SHARES OF COMMON STOCK (Filed With SEC on March 26, 2010)
- RADIENT PHARMACEUTICALS CORPORATION Convertible Promissory Note (Filed With SEC on March 26, 2010)
- NOTE AND WARRANT PURCHASE AGREEMENT (Filed With SEC on March 26, 2010)
- WAIVER OFDEFAULT (Filed With SEC on March 16, 2010)
- EXCHANGEAGREEMENT (Filed With SEC on March 16, 2010)
- No. __________ $______________ Tustin, California [FORMOF REG D NOTE] AMDL,INC. 12%SENIOR PROMISSORY NOTE DUE:_________, 2010 (Filed With SEC on March 16, 2010)
- WAIVER OF TRIGGER EVENT (Filed With SEC on December 16, 2009)
- WAIVER OF DEFAULT (Filed With SEC on December 16, 2009)
- No. __________$______________Tustin, California [FORM OF] AMDL, INC. 12% SERIES2 SENIOR PROMISSORY NOTE DUE: ______________, 2012 (Filed With SEC on December 16, 2009)
- SECURITIES PURCHASE AGREEMENT (Filed With SEC on December 2, 2009)
- COMMON STOCK PURCHASE WARRANT RADIENT PHARMACEUTICALS CORPORATION Warrant Shares: _______Initial Exercise Date: November __, 2009 (Filed With SEC on December 2, 2009)
- 1,644,643 Units RADIENT PHARMACEUTICALS CORPORATION (F/K/A AMDL, INC.) CONSISTING OF COMMON STOCK (PAR VALUE $0.001) AND WARRANTS WITH AN EXERCISE PRICE OF $1.25 PLACEMENT AGENT... (Filed With SEC on December 2, 2009)
